Pulmonary tumor thrombotic microangiopathy due to lung adenocarcinoma with ROS1 rearrangement successfully treated with Crizotinib under veno-arterial extracorporeal membrane oxygenation.

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Pulmonary circulation Clinical ESC Premium Access ESC Congress 2019

ESC 365 is supported by

ESC 365 is supported by